Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits
In the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond Glycemic Benefits. We are excited to bring you Episode 3 of the Right Turn Show, featuring two eminent experts in their respective fields: Dr Jamshed J. Dalal – Interventional Cardiologist & Honorary Director of Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital, Mumbai. Dr Pramila Kalra is a Renowned Endocrinologist, Professor, & Head of Endocrinology, Ramaiah Medical College & Hospital, Bangalore.
Dapagliflozin is widely used for managing Type 2 Diabetes and has proven benefits in treating heart failure and chronic kidney disease (CKD).
In this episode, Dr Dalal and Dr Kalra will discuss its expanded role beyond glycemic control, covering:
- Long-Term Benefits and First-Line Use of Dapagliflozin in Indian T2DM Care
- Clinical Benefits of Dapagliflozin on Intermediate Cardiovascular Risk Markers in Primary Prevention
- Initiating Dapagliflozin-Sitagliptin Dual and Triple FDC in Uncontrolled T2DM: Timing and Benefits
- Recent Cardiovascular Endpoint Benefits of Dapagliflozin in T2DM
- Nephroprotective and Clinical Endpoint Benefits of Dapagliflozin in T2DM with CKD
- Recent Cardiovascular Endpoint Benefits of Dapagliflozin in Heart Failure
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.